ABA Criminal Justice Section Plans Securities Fraud And Health Care Fraud Program

The American Bar Association’s Criminal Justice Section, White Collar Crime Committee, Mid-Atlantic Region, is having an important financial fraud program on March 9 at Seton Hall University School of Law in Newark, N.J. “Current Issues in Securities Fraud, Health Care Fraud and Corporate Investigations & Prosecutions” will begin with opening remarks by Paul J. Fishman, U.S. Attorney for the District of New Jersey. 

The program, sponsored by the law firm of Gibbons P.C., then will have a panel discussing securities fraud. Here, panelists will discuss how the changing legal landscape affects compliance, investigations and prosecutions. The moderator for this panel is John J. Carney, Baker & Hostetler - Co-Leader White Collar Defense & Corporate Investigations Group. Panelists are:
 
Joseph P. Dever, Securities & Exchange Commission
Justin Arnold, AUSA, U.S. Attorney’s Office, District of New Jersey
Mark Gerber, PricewaterhouseCooopers LLP
Patrick L. Rocco, Shalov, Stone, Bonner and Rocco
R. Scott Garley, Gibbons P.C.
 
Another program is entitled, “Strict Liability for Officers and Managing Employees at Pharmaceutical & Device Manufacturers." Here, panelists will discuss the government’s accelerating efforts to hold individuals accountable for corporate wrongdoing.
 
This panel will be moderated by Bruce A. Levy of Gibbons P.C. Panelists are:
 
Geeta Kaveti, Associate Counsel, HHS-OIG
Maureen Ruane, Unit Chief Healthcare & Government Fraud Section, U.S. Attorney’s Office for the District of New Jersey
Jonathan Diesenhaus, Hogan Lovells
Christopher D. Zalesky, Vice President Global Policy & Guidance, Johnson & Johnson
Office of Health Care Compliance & Privacy
 
Panelists at a third program, “Surviving Government Investigations & Prosecutions,” will discuss factors that enter into decisions to prosecute corporations and will assess the roles of executives and defense counsel pre- and post-indictment, including navigating the requirements of Deferred Prosecution Agreements and Corporate Integrity Agreements.
 
The moderator will be Mark S. Olinsky of Sills Cummis & Gross P.C., co-chair, Health Care Government Investigations Practice Group.
 
Panelists are:
 
Tom Eicher, Chief of the Criminal Division, U.S. Attorney’s Office for the
District of New Jersey
Marc P. Ferzan, Executive Assistant Attorney General, New Jersey
Lawrence S. Lustberg, Chair, Criminal Defense Department, Gibbons P.C.
Lawrence P. Platkin, Vice President and Compliance Officer, Bayer Healthcare LLC